加拿大OraSure Technologies
OraSure 技术有限公司使用其特有的唾液检测技术，开发、制造、销售了唾液采样仪。其诊断产品包括免疫分析以及其他体外诊断仪、医疗仪器等。这些产品在美国以及全世界的临床实验室、经销商、政府机构以及医疗、商业和工业机构进行销售。

除此以外，OraSure还在美国、加拿大、部分欧洲国家、澳大利亚、新西兰的非处方与零售市场，销售冷冻去除寻常疣、足底疣的产品，并在美国和众多国家的专业或者医疗市场提供冷冻去除寻常疣、足底疣以及其他良性皮肤损伤的产品。
 
Based in Bethlehem, Pennsylvania, OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions.

These products include tests for the detection of antibodies to the HIV virus, including OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral Specimen Collection Device, a test for antibodies to the HCV virus, the OraQuick® HCV Rapid Antibody Test, and oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test.

OraSure also manufactures and sells several leading cryosurgical products. These include: Histofreezer®, a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product for the cryosurgical removal of common and plantar warts.

In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the Company also is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities.